Thereafter, an investigation by Guerrieri and colleagues (2013) determined the transcription factors and signaling pathways that regulate NIS expression in CCA, HCC and primary human hepatocytes (PHH) (35). This evidence concerns the gene SLC5A5 and cholangiocarcinoma.